FDA Clears Stat Profile Prime Plus Analyzer for Point-of-Care Use
Agency clearance will allow healthcare personnel to perform bedside critical care testing, with lab-quality results in as little as 1 minute.
Read MorePosted by Laurie Bonner | May 11, 2020 | Blood Gas Analyzers |
Agency clearance will allow healthcare personnel to perform bedside critical care testing, with lab-quality results in as little as 1 minute.
Read MorePosted by | Apr 8, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Test results can be obtained within 15 minutes from a simple fingerstick, utilizing Chembio’s MicroReader 1 and MicroReader 2 analyzers.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read MorePosted by Steve Halasey | Mar 24, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
The agency’s EUA grants permission for Cepheid’s test to be used in high- and moderate-complexity CLIA-certified laboratories as well as in certain patient care settings.
Read MorePosted by Steve Halasey | Mar 9, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Building upon the existing Accula molecular platform, Mesa’s coronavirus test aims to deliver accurate and accessible testing close to the patient, providing critical information to healthcare providers in China, the United States, and other affected countries
Read More